Related Experiment Video
Updated: Jan 27, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Neuroprotective Influence of miR-301a Inhibition in Experimental Cerebral Ischemia/Reperfusion Rat Models Through
Tao Feng1, Bang-Hua Han1, Gong-Li Yang1
1Department of Neurosurgery, Shanxian Central Hospital, Shanxian, 274300, Shandong, China.
Abstract:
The objective of this study is to find out the potential influence of miR-301a in an experimental cerebral ischemia-reperfusion (I/R) rat model through targeting NDRG2. Rats with cerebral I/R injury were constructed and classified into model, miR-301a inhibitor, miR-301a mimic, NC (negative control), siNDRG2, NDRG2, and miR-301a inhibitor + si-NDRG2 groups, as well as another sham group. Cerebral infarct volume and cell apoptosis were observed by TTC staining and TUNEL staining. The targeting relationship between miR-301a and NDRG2 was verified by luciferase assay. ELISA, qRT-PCR, and Western blot were used to detect the expressions of related molecules. Compared with sham group, rats in the model group had elevated neurological function score and infarct volume; meanwhile, the cell apoptosis rate and inflammatory response were also increased with enhanced expression of miR-301a and NDRG2 (all P < 0.05). These changes were worsened in the miR-301a mimic and si-NDRG2 groups. Conversely, those rats in the miR-301a inhibitor and NDRG2 groups presented increased NDRG2, and at the same time, other above concerning factors also exhibited opposite tendencies (all P < 0.05). Dual-luciferase reporter gene assay confirmed that NDRG2 was a target gene of miR-301a, and si-NDRG2 could reverse the neuroprotective effect of miR-301a inhibitor in rats with cerebral I/R injury. Inhibiting miR-301a has a neuroprotective effect on rats with cerebral I/R injury to ameliorate cell apoptosis and inflammatory response through possibly targeting NDRG2.
Insights
Inhibiting microRNA-301a (miR-301a) shows neuroprotective effects in cerebral ischemia-reperfusion injury by reducing cell apoptosis and inflammation. This occurs possibly by targeting NDRG2, suggesting a new therapeutic avenue.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cerebral ischemia-reperfusion (I/R) injury is a critical condition with significant neurological consequences.
- MicroRNAs (miRNAs) play crucial roles in regulating cellular processes, including those involved in I/R injury.
- The specific role of miR-301a in cerebral I/R injury and its potential molecular targets require further elucidation.
Purpose of the Study:
- To investigate the influence of miR-301a on experimental cerebral ischemia-reperfusion (I/R) injury in a rat model.
- To explore the potential targeting relationship between miR-301a and NDRG2 in the context of cerebral I/R injury.
- To evaluate the therapeutic potential of modulating miR-301a levels for mitigating I/R-induced damage.
Main Methods:
- Establishment of a rat model for cerebral I/R injury with various experimental groups (model, sham, miR-301a inhibitor, miR-301a mimic, siNDRG2, NDRG2, and combined treatments).
- Assessment of cerebral infarct volume and cell apoptosis using TTC and TUNEL staining, respectively.
- Verification of the miR-301a and NDRG2 interaction using dual-luciferase reporter gene assay; quantification of molecular expressions via ELISA, qRT-PCR, and Western blot.
Main Results:
- Rats with cerebral I/R injury exhibited increased neurological deficit, infarct volume, cell apoptosis, and inflammatory response, accompanied by elevated miR-301a and NDRG2 expression compared to the sham group.
- Administration of miR-301a inhibitor or NDRG2 reversed these detrimental effects, while miR-301a mimic or siNDRG2 exacerbated them.
- Dual-luciferase assay confirmed NDRG2 as a direct target of miR-301a, and knockdown of NDRG2 counteracted the protective effects of the miR-301a inhibitor.
Conclusions:
- Inhibiting miR-301a demonstrates a significant neuroprotective effect in cerebral I/R injury rats.
- This protective mechanism involves the amelioration of cell apoptosis and inflammatory response, likely through the downregulation of its target gene, NDRG2.
- Modulating miR-301a-NDRG2 interaction presents a potential therapeutic strategy for treating cerebral ischemia-reperfusion injury.
Related Concept Videos
Feedback Inhibition
Enzyme Inhibition
Bioavailability: Influencing Factors
The Influence of Affect on Cognition
The Influence of Cognition on Affect
Inhibition of Cdk Activity

